0000899243-21-049427.txt : 20211222 0000899243-21-049427.hdr.sgml : 20211222 20211222182147 ACCESSION NUMBER: 0000899243-21-049427 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211221 FILED AS OF DATE: 20211222 DATE AS OF CHANGE: 20211222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dahms Bradford D. CENTRAL INDEX KEY: 0001787307 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40869 FILM NUMBER: 211514345 MAIL ADDRESS: STREET 1: C/O SELECTA BIOSCIENCES, INC. STREET 2: 480 ARSENAL WAY CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Theseus Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001745020 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 830712806 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (857) 400-9491 MAIL ADDRESS: STREET 1: 245 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-21 0 0001745020 Theseus Pharmaceuticals, Inc. THRX 0001787307 Dahms Bradford D. C/O THESEUS PHARMACEUTICALS, INC. 245 MAIN STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Financial Officer Common Stock 2021-12-21 4 P 0 1970.036 10.1521 A 1970.036 D The price reported is a weighted average price of shares purchased. These shares were purchased in multiple transaction at prices ranging from $10.09 to $10.28, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. /s/ Bradford Dahms 2021-12-22